Broad dengue neutralization in mosquitoes expressing an engineered antibody
Open Access
- 1 January 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Pathogens
- Vol. 16 (1), e1008103
- https://doi.org/10.1371/journal.ppat.1008103
Abstract
Author summary With limited success of traditional vector control methods to curb dengue infections and more than half of the world's population still at risk, there is a need for novel strategies to reduce its impact on public health. Recent advances in genetic technologies has allowed for precise modifications of mosquito genome to make them resistant to infections, thus breaking the transmission cycle. Here we generated engineered Ae. aegypti mosquitoes efficiently expressing a DENV-targeting single-chain variable fragment (scFv) derived from a previously characterized broadly neutralizing human antibody, which blocked infection and transmission in these mosquitoes. To our knowledge, this is the first example of an engineered transgene capable of rendering Ae. aegypti mosquitoes 100% refractory to all four serotypes of DENV. The engineered mosquitoes, in future, could easily be paired with a gene drive, capable of spreading the transgene throughout wild disease-transmitting mosquito populations and preventing further DENV transmission. Since a number of diverse and well-characterized antibodies exist against other arboviruses (eg chikungunya and Zika, this work also provides a proof-of-concept principle for developing similar genetic strategies for reducing the impact of these arboviruses. With dengue virus (DENV) becoming endemic in tropical and subtropical regions worldwide, there is a pressing global demand for effective strategies to control the mosquitoes that spread this disease. Recent advances in genetic engineering technologies have made it possible to create mosquitoes with reduced vector competence, limiting their ability to acquire and transmit pathogens. Here we describe the development of Aedes aegypti mosquitoes synthetically engineered to impede vector competence to DENV. These mosquitoes express a gene encoding an engineered single-chain variable fragment derived from a broadly neutralizing DENV human monoclonal antibody and have significantly reduced viral infection, dissemination, and transmission rates for all four major antigenically distinct DENV serotypes. Importantly, this is the first engineered approach that targets all DENV serotypes, which is crucial for effective disease suppression. These results provide a compelling route for developing effective genetic-based DENV control strategies, which could be extended to curtail other arboviruses.Keywords
Funding Information
- Defense Advanced Research Projects Agency (HR0011-17-2- 0047)
This publication has 78 references indexed in Scilit:
- THE IMPORTANCE OF MOSQUITO BEHAVIOURAL ADAPTATIONS TO MALARIA CONTROL IN AFRICAEvolution, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Open Field Release of Genetically Engineered Sterile Male Aedes aegypti in MalaysiaPLOS ONE, 2012
- Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based ConsensusPLoS Neglected Tropical Diseases, 2012
- Transgenic Anopheles stephensi coexpressing single-chain antibodies resist Plasmodium falciparum developmentProceedings of the National Academy of Sciences, 2012
- Engineered Resistance to Plasmodium falciparum Development in Transgenic Anopheles stephensiPLoS Pathogens, 2011
- Transgene‐mediated suppression of dengue viruses in the salivary glands of the yellow fever mosquito, Aedes aegyptiInsect Molecular Biology, 2010
- Activation of Akt Signaling Reduces the Prevalence and Intensity of Malaria Parasite Infection and Lifespan in Anopheles stephensi MosquitoesPLoS Pathogens, 2010
- Epitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized AntibodyJournal of Virology, 2007
- Engineering RNA interference-based resistance to dengue virus type 2 in genetically modified Aedes aegyptiProceedings of the National Academy of Sciences of the United States of America, 2006